Giuseppe Lucente
Giuseppe Lucente
Hospital Universitario Germans Trias i Pujol
Dirección de correo verificada de
Citado por
Citado por
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta …
BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ...
The Lancet Neurology 17 (1), 47-53, 2018
Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion
M Ribo, CA Molina, E Cobo, N Cerdà, A Tomasello, H Quesada, ...
Stroke 47 (4), 999-1004, 2016
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ...
The Lancet Neurology 17 (10), 895-904, 2018
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis …
BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ...
The Lancet Neurology 18 (1), 46-55, 2019
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
A Dávalos, E Cobo, CA Molina, A Chamorro, MA de Miquel, L San Román, ...
The Lancet Neurology 16 (5), 369-376, 2017
Relevance of prehospital stroke code activation for acute treatment measures in stroke care: a review
M Baldereschi, B Piccardi, A Di Carlo, G Lucente, D Guidetti, D Consoli, ...
Cerebrovascular Diseases 34 (3), 182-190, 2012
Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment
M Nesi, G Lucente, P Nencini, L Fancellu, D Inzitari
Journal of Stroke and Cerebrovascular Diseases 23 (2), 204-208, 2014
Patient‐related features associated with a delay in seeking care after stroke
S Abilleira, G Lucente, A Ribera, G Permanyer‐Miralda, M Gallofré
European journal of neurology 18 (6), 850-856, 2011
Stroke unit care in clinical practice: an observational study in the Florence center of the European Registers of Stroke (EROS) Project
A Di Carlo, M Lamassa, I Wellwood, F Bovis, M Baldereschi, P Nencini, ...
European Journal of Neurology 18 (5), 686-694, 2011
TMS motor mapping in brain tumor patients: more robust maps with an increased resting motor threshold
S Lam, G Lucente, H Schneider, T Picht
Acta Neurochirurgica 161 (5), 995-1002, 2019
Manifesting heterozygotes in McArdle disease: a myth or a reality—role of statins
J Núñez-Manchón, A Ballester-Lopez, E Koehorst, I Linares-Pardo, ...
Journal of inherited metabolic disease 41 (6), 1027-1035, 2018
A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype
A Ballester‐Lopez, E Koehorst, M Almendrote, A Martínez‐Piñeiro, ...
Human Mutation 41 (2), 420-431, 2020
ECOG or Karnofsky performance status to assess functionality in glioblastoma patients among different observers
C Panciroli, A Estival, G Lucente, JM Velarde, R García
Mol Biomark Diagn 2, 032, 2017
Myotilinopathy unmasked by statin treatment: A case report
A Ramos-Fransi, A Martínez-Piñeiro, M Almendrote, G Lucente, C Carrato, ...
Muscle & nerve 57 (6), E138-E140, 2018
Preservation of motor maps with increased motor evoked potential amplitude threshold in RMT determination
G Lucente, S Lam, H Schneider, T Picht
Acta Neurochirurgica 160 (2), 325-330, 2018
Three-dimensional imaging in myotonic dystrophy type 1: Linking molecular alterations with disease phenotype
A Ballester-Lopez, J Núñez-Manchón, E Koehorst, I Linares-Pardo, ...
Neurology Genetics 6 (4), 2020
The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1
A Ballester-Lopez, I Linares-Pardo, E Koehorst, J Núñez-Manchón, ...
Genes 11 (7), 757, 2020
Noninvasive Brain Stimulation and Noninvasive Peripheral Stimulation for Neglect Syndrome Following Acquired Brain Injury
G Lucente, J Valls‐Sole, N Murillo, J Rothwell, J Coll, A Davalos, H Kumru
Neuromodulation: Technology at the Neural Interface 23 (3), 312-323, 2020
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab
C Panciroli, G Lucente, L Vidal, E Carcereny, V Quiroga, JC Pardo, ...
Clinical and Translational Oncology 22 (3), 411-419, 2020
Are anti-ganglioside antibodies detectable in serum from patients with critical illness myopathy and polyneuropathy?
A Martínez-Piñeiro, AR Fransi, MA Muñoz, G Lucente, EM Caceres, ...
Revista Médica de Trujillo 15 (1), 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20